Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Fehrenbacher, Louis, Spira, Alexander, Ballinger, Marcus, Kowanetz, Marcin, Vansteenkiste, Johan, Mazieres, Julien, Park, Keunchil, Smith, David, Artal-Cortes, Angel, Lewanski, Conrad, Braiteh, Fadi,Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(16)00587-0
Date:
March, 2016
File:
PDF, 658 KB
english, 2016